The concomitant use of meloxicam and methotrexate does not clearly increase the risk of silent kidney and liver damages in patients with rheumatoid arthritis

@article{Park2013TheCU,
  title={The concomitant use of meloxicam and methotrexate does not clearly increase the risk of silent kidney and liver damages in patients with rheumatoid arthritis},
  author={Hee-Jin Park and Min Chan Park and Yong-Beom Park and Soo-Kon Lee and Sang-Won Lee},
  journal={Rheumatology International},
  year={2013},
  volume={34},
  pages={833-840}
}
We investigated whether the concomitant use of meloxicam and methotrexate might induce kidney and liver damages in patients with rheumatoid arthritis (RA). We enrolled 101 RA patients with normal kidney and liver functions taking meloxicam and methotrexate concomitantly for more than 6 months. Blood and urine tests were performed. Estimated glomerular filtration rate (eGFR) and liver stiffness measurement (LSM) were used for evaluating silent kidney and liver damages. Ultrasonography was also… CONTINUE READING
1 Citations
38 References
Similar Papers

References

Publications referenced by this paper.
Showing 1-10 of 38 references

griffiths HR (2003) the anti-inflammatory actions of methotrexate are critically dependent upon 840 Rheumatol Int (2014) 34:833–840 1 3 the production of reactive oxygen species

  • Phillips Dc, KJ Woollard
  • Br J Pharmacol
  • 2014
1 Excerpt

gisbert JP (2012) evaluation of liver fibrosis by transient elastography (Fibroscan(R)) in patients with inflammatory bowel disease treated with methotrexate: a multicentric trial

  • Barbero-Villares a, J MendozaJimenez-Ridruejo, +8 authors J Mate
  • Scand J gastroenterol
  • 2012
1 Excerpt

Similar Papers

Loading similar papers…